APACC
Meeting category
Date(s)
16 Jun 2022 - 18 Jun 2022
Meeting type
Virtual Meeting
Organizer

APACC 2022

Related Enduring Materials

Enduring Materials
- parallel sessions

Day 1 - Thursday, 16 June 2022

Plenary Session 1: Opening Session -
Aging Patients: Immune Activation in Elderly People Living with HIV
Peter Hunt, MD
University of California San Francisco, United States
COVID-19 in People Living with HIV: Social Inequality and COVID-19
Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc HonLLD Monash, DPMP
President and Pro Vice Chancellor, Monash University, Malaysia
Recent Advances in the Treatment of Tuberculosis: Shorter Regimens for Drug-Susceptible and Resistant TB
Nicholas Paton, MD, FRCP
National University of Singapore, Singapore
Parallel Session 1: The Aging Patient -
Neuro Cognitive Complications of Aging - The Clinical Perspective
Grace Chung-Yan Lui, MBChB (Hons), FHKCP, FHKAM
The Chinese University of Hong Kong, Hong Kong
Neuro Cognitive Complications of Aging - The Social Perspective
Andrew Tan Tze Tho
Kuala Lumpur AIDS Support Services Society, Malaysia
Parallel Session 2: Abstract-Driven Presentations - Coinf- STI -
Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis
Helen Xu
Duke University, United State
High Sexually Transmitted Infection Prevalence / Incidence Among New, Current, and Non-Users of Pre-Exposure Prophylaxis and HIV-Positive Men Who Have Sex with Men and Transgender Women Attending Key Population-Led Clinics in Thailand
Narukjaporn Thammajaruk
Institute of HIV Research and Innovation, Thailand
Intensified Screening for Mycobacterial Infections Using Gen-xpert Directly in Blood and Mycobacterial Culture in Hospitalized Patients with Advanced HIV Diseases in Vietnam
Dieu Nguyen
Oxford University Clinical Research Unit, Vietnam
Pre-Treatment HCV RNA Testing Among People Living with HIV Co-Infected with HCV in the Asia-Pacific Region
Dhanushi Rupasinghe
The Kirby Institute, UNSW Sydney, NSW, Australia
Effects of HIV-Integrated TB interventions on Care Continuum Outcomes for Active TB: A Systematic Review and Meta-Analysis
Gifty Marley
University Of North Carolina Chapel Hill-china Project
Impact of COVID-19 Lockdown on Testing for and Diagnoses of Sexually Transmitted Infections in Bangkok, Thailand
Napon Pungpapong
Winchester College, Thailand
Capacity-Building Session 1: For Us, and By Us: Crowdfunding and Public Engagement in Health Research -
Systematic Review and Crowdfunding Practical Guide
Eneyi Kpokiri, PhD
London School of Hygiene and Tropical Medicine, London, United Kingdom
What Makes a Successful Online Campaign?
Rayner Kay Jin Tan, PhD
Saw Swee Hock School Of Public Health, National University Of Singapore, Singapore
Harnessing Online and Offline Methods for Crowdfunding in Thailand
Teerawat Wiwatpanit, PhD
National Center for Genetic Engineering and Biotechnology, Thailand

Day 2 - Friday, 17 June 2022

Capacity-Building Session 2: Maintaining a Focus on HIV and STIs in the Era of COVID-19 – Stories and Lessons from the Pacific Region -
Introduction
Kasha Priya Singh, MBBS, MPH, FRACP
The Peter Doherty Institute for Infection and Immunity, Australia
Wokforce Challenges Over the Past 2 Years, Highlighted with Examples
Scott McGill
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), Australia
Lessons Learnt and Ways Forward – Building a Resilient Health Workforce
Renata Ram
United Nations Program on HIV/AIDS (UNAIDS), Republic of Fiji
Plenary Session 2: PrEP in Key Populations -
Differentiated & Simplified PrEP for HIV Prevention
Heather-Marie Schmidt, BMedSc (Hon), MPH, PhD
UNAIDS Regional Office for Asia and the Pacific, Thailand and the Global HIV, Hepatitis and STIs Programme, World Health Organisation, Switzerland
Implementation of PrEP - Vietnam's Experience with Self-Testing
Parallel Session 3: Opportunistic Infections -
Burden of Systemic Mycoses in Advanced HIV Disease in Vietnam
Vu Quoc Dat, MD, PhD
Hanoi Medical University, Vietnam
Talaromycosis - A Leading Cause of Death in Patients with Advanced HIV Disease in Southern China
Hao Liang, M.D., Ph.D.
Life Sciences Institute, Guangxi Medical University, China
Parallel Session 4: Abstract-Driven Presentations - New Drug-Delivery -
Weight Change when Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV
Warittha Tieosapjaroen
Monash University, Australia
Rapid Tenofovir-Lamivudine-Dolutegravir Transition in Papua New Guinea: A Virtual Approach to Antiretroviral Prescriber Refresher Trainings During a Global Pandemic
Poruan Temu
FHI360, Papua New Guinea
Asian Phase 3/3b Experience With Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes Through Week 96
Shinichi Oka
National Center For Global Health And Medicine, Japan
Higher CD4/CD8 Ratio Recovery Observed Among People Living with HIV Started with Integrase Strand Transfer Inhibitors
Win Min Han
The Kirby Institute, UNSW Sydney, Australia
Real-World Efficacy of INSTI-Containing Antiretroviral Therapy in Treatment-Naïve People Living with HIV
Yayoi Nakamura
National Center For Global Health And Medicine, Japan
Implementation Strategies to Enable Initiation of Same-day Antiretroviral Therapy by Lay Providers in Two Community Based Organizations in Bangkok, Thailand
Rena Janamnuaysook
Institute of HIV Research and Innovation, Thailand
Guided Poster Tour 1: Digital Health -
Effectiveness of Sexual Health Influencers Identified by an Ensemble Machine Learning Model in Promoting Secondary Distribution of HIV Self-Testing Among Men who have Sex with Men in China: A Quasi-experimental Trial
Ying Lu
UNC Project-China, China
The International Sexual Health and Reproductive Health Survey (I-SHARE-1): A Multi-Country Analysis of Sexual Behaviors and HIV/STI Prevention Access Prior to and During the Initial COVID-19 Wave in 30 Countries
Rayner Kay Jin Tan, PhD
Saw Swee Hock School Of Public Health, National University Of Singapore, Singapore
Digital Crowdsourced Intervention to Enhance Viral Hepatitis Testing in Primary Care: A Randomized Controlled Trial in China
Gifty Marley
University Of North Carolina Chapel Hill- China Project, China
Social Network Strategy to Promote HIV Testing and Linkage to HIV Services Among Adolescents in Thailand.
Nantika Paiboon
Department Of Pediatrics, Faculty Of Medicine, Chulalongkorn University, Thailand
Guided Poster Tour 2: NCDs-comorbid -
Prevalence of and Factors Associated With Diabetes Mellitus Among People Living with HIV in Vietnam
Moeko Nagai
Aids Clinical Center, National Center For Global Health And Medicine, Japan
Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Obese and Non-Obese Patients With and Without HIV Infection in Asia
Thanathip Wichiansan
The Hiv Netherlands Australia Thailand Research Collaboration (hiv-nat), Thailand
A Prospective Immunogenicity Study of a Quadrivalent Influenza Vaccine Among HIV-Infected Patients with Different Levels of CD4 Cell Count
Suparerk Satanon
Department Of Medicine, Faculty Of Medicine Ramathibodi Hospital, Mahidol University, Thailand
Preliminary Findings from a Pre-Implementation Study on Integrating Screening for HIV-Associated Neurocognitive Disorders (HAND) into Routine HIV Care in Malaysia
Pui Li Wong
Universiti Malaya, Malaysia
Guided Poster Tour 3: Mental Health -
Assessing the Acceptability and Feasibility of an Integrated Telebehavioral Health System in Primary HIV Care Settings in the Philippines
Timothy John Dizon
Research Institute For Tropical Medicine, Philippines
Integration of a Peer-Led Depression Screening and Linkage-to-Care intervention Among Transgender Women Living With and at Risk for HIV at a Transgender-Led Health Clinic in Bangkok, Thailand
Rena Janamnuaysook
Institute of HIV Research and Innovation, Thailand
Assessing the Acceptability and Feasibility of a Collaborative Care Model for Managing Anxiety and Depression Utilizing HIV Counsellors as Care Managers in HIV Clinics in the Philippines
Anna Maureen Dungca-Lorilla
Research Institute For Tropical Medicine, Philippines
Assessment Demonstrates Gaps in Services to Support Mental Health of HIV Providers and their Clients During the COVID-19 Pandemic in Vietnam
Van Thu Pham
FHI 360, Vietnam
Guided Poster Tour 4: PrEP Serv -
PrEP Pop-Up: A Targeted Community-Led Approach to Convenient PrEP Access in Metro Manila
Ron Jacob Calumpang
HIV & AIDS Support House, Inc.Philippines
Introduction of Gain-Framed Pre-Exposure Prophylaxis Counseling Increased Uptake Among Transgender Women at the Tangerine Clinic, Bangkok, Thailand
Peevara Srimanus
Institute of HIV Research and Innovation, Thailand
Potential USe of Pooled Point-of-Care HIV-1 Viral Load to Detect HIV Infection at PrEP Initiation and Follow-Up Visits in Key Population-Led PrEP Clinics in Thailand
Narukjaporn Thammajaruk
Institute of HIV Research and Innovation, Thailand
Not Just About Knowledge and Money: Most Taiwanese Sexual Health Physicians Require Standard Operating Procedure and Non-Physician Professionals’ Support to Deliver PrEP Services
Isaac Yen-Hao Chu
London School of Hygiene and Tropical Medicine, Department of Public Health, Environments and Society, United Kingdom

Day 3 - Saturday, 18 June 2022

Parallel Session 5: Mental Health -
Addressing Suicide
Brian J. Hall, PhD
NYU Shanghai, China
Mental Health in Young Adults
Wipaporn Natalie Songtaweesin, MBBS, DTMH
Chulalongkorn University, Thailand
Parallel Session 6: Viral Hepatitis -
Epidemiology of Hepatitis Delta in the Asian Region – Do We Need Screening & What Are the Treatment Options?
Chien-Ching Hung, MD, PhD
National Taiwan University Hospital & National Taiwan University Hospital Yunlin Branch / National Taiwan University College of Medicine, Taiwan
Practical Implementation of Elimination Plans (HBV/HCV) - The Impact of Testing in Primary Care Setting
Capacity Building Session 3: Implementation Science: Linking Research to Policy -
Introduction
Wipaporn Natalie Songtaweesin, MBBS, DTMH
Chulalongkorn University, Thailand
Global Perspective
Meg Doherty, MD, PhD
WHO, Switzerland
Donor / Implementer Perspective
Pimpanitta Saenyakul, PhD, MPH, BSN-RN
USAID Regional Development Mission for Asia (RDMA), Thailand
Parallel Session 7: New ARVs/Formulations/Strategies -
New Antiretroviral Drugs/Formulations for the Treatment of PLWH and for Prevention of HIV
Jennifer Hoy, AM, FRACP, FAHMS
Monash University, Australia
New Development of Therapeutics for COVID Treatment
Steve McGloughlin, Bsc, BMed, FCICM, FRACP, MPH&TM, PGDipEcho
National COVID-19 Clinical Evidence Taskforce, Australia
Parallel Session 8: Abstract-Driven Presentations - Substance use -
Differences in Methamphetamine Use Characteristics Among People with Opioid Use Disorders Under Methadone Treatment in The Two Big Cities in Vietnam: Preliminary Analysis from the STAR-OM Study
Nguyen Thu Trang
Hanoi Medical University, Vietnam
Recreational Drugs are Associated with Viral Load Blips and Lower Adherence in a Prospective Cohort of Thai People with Acute HIV Infection
Camilla Muccini
SEARCH, Institute Of Hiv Research And Innovation, Thailand
Homoprejudiced Violence Experience, Depression, and High-Risk Sex Behavior Among MSM in China: A Mediation Analysis
Xumeng Yan
UNC Project-China, China
Linking Female Entertainment Workers in Cambodia to HIV, Sexual and Reproductive Health, and Gender-Based Violence Services: The Mobile Link Randomized Controlled Trial
Siyan Yi
National University Of Singapore, Singapore
Facilitators and Barriers to the Integration of Depression and Substance Use Screening and Linkage to Care Among People Living with HIV in a Tertiary-care Hospital in Malaysia: A Qualitative Study
Meng Li Chong
University Of Malaya Medical Centre, Malaysia
Observed Increase in Methamphetamine Use Risk Among Vietnamese Methadone Patients between 2018 and 2021
Thuy Dao
Hanoi Medical University, Vietnam
Plenary Session 3: Closing Session - Digital Health & Health Innovation -
Digital Health Ecosystems and Its Implications for HIV and Other Co-Infections
Sin How Lim, PhD
University of Malaya, Malaysia
Social Innovations in Health, Especially with Implications for HIV and Other Co-Infections
Beatrice Halpaap, Pharm D, MPH
Expert advisor TDR, Switzerland

** Industry-supported Symposia programs can be visited in "Symposia" Tab.

Symposia VOD
Thursday, 16 June 2022
ViiV-supported Symposia -
Empowering a Healthy Future for People living with HIV
Giovanni Guaraldi, MD
University of Modena and Reggio Emilia, Italy
Tae-Hyong Kim
Soon Chun Hyang University Hospital, Korea.
Michelle Moorhouse, MBBCh, FRSPH
Donald Gordon Medical Centre/ViiV Healthcare, South Africa
Friday, 17 June 2022
Gilead-supported Symposium -
Ending Asia HIV Pandemic by 2030 - What's The Next Step?
Chien-Ching Hung, MD, PhD
National Taiwan University Hospital & National Taiwan University Hospital Yunlin Branch / National Taiwan University College of Medicine, Taiwan
Jun Yong Choi, MD, PhD
Yonsei University College of Medicine, Severance Hospital Seoul, South Korea
Wei Lyu, PhD
Peking Union Medical College Hospital, China
Overview
What's New

APACC 2022 Program Book

  • Registrations for APACC 2023 will soon open.
  • To stay updated on developments about APACC 2023, make sure you sign up for our newsletter.
Welcome Message

Dear colleagues,

The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2022 will be held from 16 to 18 June 2022 as a virtual program

Over the years, enormous progress has been made in the fight against HIV and co-infections with HIV. Both academia and industry have contributed greatly to equipping the medical community with the best medications and expertise possible to optimally treat their HIV and co-infected patients. However, international platforms for scientific interchange are not always accessible to medical professionals worldwide due to budget and travel restrictions. Also, most major conferences do not usually address local and regional issues. In particular, the Asian medical community in this field of research currently has very few platforms that serve the needs of HIV healthcare professionals in this region.

APACC provides a much-needed scientific platform that focuses on the developments, issues, and needs in the Asia-Pacific region. Researchers have the opportunity to present and discuss the latest developments and are offered opportunities for interaction, networking, and building collaborations. Top experts integrate science and clinical practice through state-of-the-art lectures, clinical case discussions, round table discussions, and debates in order to reach consensus on best practices and inform how treatment guidelines are implemented.

We look forward to meeting you virtually at APACC 2022!

Nittaya Phanuphak, Reena Rajasuriar, and Joseph Tucker.

Co-chairs, APACC 2022

COVID-19 Update
Responding to the changing COVID-19 situation, the Asia-Pacific AIDS & Co-infections Conference (APACC) 2022 will be held as a virtual conference from 16 -18 June 2022.

We are available to answer any questions or concerns that you may have about your participation at APACC 2022. For more information, please contact us via yeening.tham@amededu.com.
Practical Information
Language
The official language of the meeting is English. Translation to Chinese will be provided.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Certificate of Attendance
A certificate of attendance will be sent to participants after they successfully complete the program and the post-meeting survey.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official conference sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the conference is finished, provided the speaker has given permission to do so.
Registration
  • Registration for APACC 2022 is closed.

  • Registration for APACC 2023 is now open. Click here to register.

Accreditation

APACC 2022 is accredited by the following societies. To claim the CME points, members of the societies must log on to the virtual congress portal and attend the full sessions. Additional information such as membership number or license number might be required after the event.

Hong Kong Academy of Medicine (HKAM)
HKAM

APACC 2022 is accredited by the Hong Kong Academy of Medicine (HKAM) up to 12 credits. To claim the CME points, members of the HKAM must log on to the virtual congress portal and attend the full sessions. 

 

 College 

   16 June 

   17 June 

   18 June 

Physicians 

      3.5

 CME Points

      4.5 

 CME Points

       3.5 

CME Points

Infectious Diseases Association of Thailand (IDAT)
Infectious Disease Association of Thailand

APACC 2022 is accredited by the Infectious Diseases Association of Thailand (IDAT) up to 14.5 credits. To claim the CME points, members of the IDAT must log on to the virtual congress portal and attend the full sessions. 

   16 June 

    17 June 

    18 June 

      4.75

 CME Points  

       4.75

  CME Points

         5

CME Points

European Accreditation Council for Continuing Medical Education (EACCME®)
European Accreditation Council for Continuing Medical Education (EACCME®)

The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2022, Virtual,   Netherlands, 16/06/2022-18/06/2022 has been accredited by the European   Accreditation Council for Continuing Medical Education (EACCME®) with 11   European CME credits (ECMEC®s). Each medical specialist should claim only   those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes  and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities. 

Taiwan AIDS society
Taiwan AIDS Society

APACC 2022 is accredited by the Taiwan AIDS Society with 4 credits. To claim the CME points, members of the Taiwan AIDS Society must log on to the virtual congress portal and attend the full sessions. 

Committees
Chairs 2022
Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee
Hung, Chien-Ching 2023
Chien-Ching Hung, MD, PhD
National Taiwan University Hospital & National Taiwan University Hospital Yunlin Branch / National Taiwan University College of Medicine, Taiwan

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

APACC Fellows (2021-2022)

The purpose of the APACC Fellows Program is to provide early-career investigators with an opportunity to learn about HIV and co-infection research, conference organization, and leadership through serving on the Organizing Committee of APACC. Fellows will help to develop conference session content for other early-career investigators and promote APACC over a two-year term. The Organizing Committee is responsible for the overall content of the conference program, driving conference engagement, and selecting abstracts and panel topics. Fellows will receive support to attend the conference for each of the two years in which they participate (remotely or in-person, as appropriate). 

Support
Bronze Level Support
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in HIV and co-infections with HIV.
 
This collaboration plays a vital role in both the organizational as well as the scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Rikke Puggaard-Rode at Rikke.Rode@amededu.com or call +31 30 230 7140.
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company. *Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Digital and printed advertising opportunities 
  • Social media shout-outs

*Subject to the support level.

Endorsers

APACC 2022 is endorsed by the following societies and organizations. Their support and collaboration are key to the success of this program!

If you would like your organization to endorse this meeting, please contact Rikke Rode at Rikke.Rode@amededu.com

Local Hub

We are delighted to announce that APACC 2022 will have two local hubs!

One in Guangzhou City, China, for around 20 delegates. This hub is supported by SESH - Social Entrepreneurship to Spur Health.

Another in Bangkok, Thailand, for around 40 delegates. This hub is supported by IHRI Institute of HIV Research and Innovation.

Should you and your organization wish to organize a local hub for APACC 2022, please do not hesitate to reach out.

Abstracts

Abstract submission is closed for APACC 2022.

APACC provides a platform for the investigators in the Asia-Pacific region to present their latest research or share their experiences in the field of HIV and co-infections with HIV! 

We welcome two types of abstracts:

  • Research abstracts: Present the latest results from your study or research and discuss the findings with an expert audience.
  • “Lessons learned” abstracts: What worked and what did not work? Share your experiences and exchange ideas with a multidisciplinary audience.

"Research abstracts" have to be submitted in a structured format (Background, Materials and Methods, Results, Conclusions), and "Lessons learned abstracts" can be submitted in a descriptive (non-structured) format.

APACC accepts encore abstracts and industry-submitted abstracts as long as the research is focused on the Asia-Pacific and has new data at the time of the conference.

Co-submission of abstracts with AIDS 2022 is allowed. Both media representatives, as well as abstract submitters to submit abstracts to both APACC 2022 and AIDS 2022, are required to comply with the AIDS 2022 embargo policy.

AIDS 2022

Once the submission is open, authors can submit their abstracts electronically until 1 April, at 23.59 GMT+7. Please follow the step-by-step directions to upload the abstract. To ensure your abstract does not contain any special characters or formatting, the abstract must be in Microsoft Word format.

General Guidelines

"Research abstracts" should contain the following four components:

  • Background: A concise statement of the issue under investigation or a hypothesis;
  • Material and Methods: The experimental methods used (including the statistical analyses employed);
  • Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
  • Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

"Lessons learned abstracts" can be submitted in a descriptive (non-structured) format.

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled. 

Terms and Conditions

By submitting an abstract to a meeting organized by Virology Education BV (VE) or Academic Medical Education BV (AME), the abstract submitter hereby agrees to the terms and conditions.

The terms and conditions can be viewed here

Categories for Abstract Submission
For purposes of review and programming, abstracts are divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

BASIC SCIENCE
- Basic Immunology and Vaccine Development (HIV, SARS-CoV2, and Others)
- Immune Responses to SARS-CoV2 Infection and Vaccination
- HIV Virology
- Latency and Viral Reservoirs
- Novel Treatment and Cure Strategies

CLINICAL SCIENCE
- Antiretroviral Drug Resistance
- Antiretroviral Therapies in Adults (Clinical Trials and Observational Cohort Studies)
- Co-Morbidities and Complications (STI and Non-Communicable Disease)
- Testing, Treatment, and Prevention of COVID-19 in PLWH and Understudied Populations
- Sexually Transmitted Infections in PLWH and Understudied Populations
- Diagnostic and Monitoring Tools
- HIV Infection and Treatment in Understudied Populations (Children, Adolescents, Women, Elderly, etc.)
- Health Outcomes in Older PLWH
- Linkage and Retention in Care
- Non-ART Strategies and Therapies
- Pharmacology of ARVs

PREVENTION SCIENCE
- Approaches for HIV Prevention
- Epidemiology and Surveillance of HIV / STIs / Hepatitis
- Feasibility and Impact of Structural Interventions
- Population-Specific Interventions and Prevention Strategies
- Prevention of Mother-to-Child Transmission
- Tools for HIV Prevention
- Behavioral HIV/STI/Hepatitis Research


IMPLEMENTATION SCIENCE
- Infrastructure and Delivery Models for the Scale-Up of Services
- Stigma

CO-INFECTIONS INCLUDING VIRAL HEPATITIS
- Diagnostics and Treatment of Co-Infections
- Epidemiology and Surveillance of Co-infections
- HBV Therapeutics and Approaches in the Co-infection Section
- HCV Therapeutics and Approaches
- Novel TB Treatment Strategies
Early-Career Professionals
We are pleased to offer a 100% discount on the Early Academia fee for early-career investigators with an accepted abstract.

IMPORTANT: the registration fee waiver is offered to the presenting author of the abstract only.

Applicants should:

- Be a current Master/ PharmD/ PhD student; OR
- Have obtained an MD/ PharmD/ PhD degree in the last five years.

An application form (available below) needs to be completed by a supervisor and received by the Virology Education at least 2 weeks before the start of the conference.

Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.
Notification of Abstract Acceptance and Presentation Format
It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. We aim to send out notifications at least 1.5 months prior to the start date of the event. Please notify the Conference Secretariat if you have not received a notification by mid-May. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.
Abstract Publication
Accepted abstracts will be published in the Abstract Book: the journal Reviews in Antiviral Therapy & Infectious Diseases. This will be distributed during the conference and will be available as an enduring material after the conference has concluded. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

VE and AME is the sole copyright holder of the conference abstract book as a whole (also referred to as the Reviews in Antiviral Therapy & Infectious Diseases). The abstract authors will retain any and all copyright over their individual abstract. Information on copyright can be viewed in the abstract submission terms and conditions (see 'Terms and Conditions' above).
Scholarships

Scholarship application is closed for APACC 2022!

The scholarship application is closed for APACC 2022. The deadline was 15 May 2022.

If you have financial concerns, don't hesitate to get in touch with the conference secretariat at yeening.tham@amededu.com.

Who Can Apply?

APACC 2022 welcomes registration scholarship applications from the following groups:

  • Academia from Resource-Limited Settings;
  • Clinical Virologists;
  • Community Health Workers / Community Lay Providers;
  • Early-Career Professionals Including Those Undergoing Training;
  • Government Representatives; 
  • NGO/CSO/Community Representatives including Advocates; 
  • People Living with HIV; 
  • Pharmacists; 
  • Pharmacologists; 
  • Practicing Clinicians / Prescribers; and 
  • Early-Career Investigators including post-graduate students.
Application Procedure
The scholarship applications can either be emailed to yeening.tham@amededu.com or be submitted online through our Scholarship Application Portal by Sunday, 15 May 2022.

The applicant will be asked to submit a motivational letter (max. 200 words) describing how their patients/research/community will benefit from the knowledge gained at this conference (mandatory). In addition, early-career investigators will be asked to submit a Early-Career Investigator form.
See downloadable forms below.

- All applications will be acknowledged upon receipt.
- All applicants will be notified about the status of their application no later than 20 May 2022.
- Successful applicants will be sent a discount code for complimentary registration.
Eligibility
Applicants must:
- Be proficient enough in English to interact with faculty and fellow attendees;
- Be actively involved in the field of HIV and/or co-infections with HIV (such as hepatitis);
- Be able to show benefits to their patients / research / community from attending the conference; and
- Be willing to share information learned at the conference with a larger community.

The organizer will automatically decline all scholarship applications that do not conform to the eligibility terms.
Scholarship Terms and Conditions
• The applicant will attend the conference.
• The applicant will provide the completed post-meeting feedback to the organizer.
• The applicant must confirm that they will be responsible for all other costs associated with conference attendance such as internet usage and use of a computer device.
• The applicant will not hold the organizer liable for any losses, costs, expenses, causes of action, claims, and suits for property damage, theft of property, or personal injury (including death) arising in connection with the Scholarship and participation in the conference.
• The applicant agrees to be responsible for taking out their relevant own insurance policies.
• The Scholarship is non-transferable.
• Incomplete Scholarship applications will not be considered.
• Retrospective Scholarship applications will not be considered.
• Organizer cannot be held responsible for any incorrect information that is submitted via email or through the Scholarship application portal.
• Scholarship applications will be considered until the exhaustion of funds.
• The Scholarship applicants will be notified of the decision by email. Successful applicants will be notified with further instructions.
• Organizer reserves the right to make the final decision regarding all Scholarship applications, which cannot be disputed.
What does the Scholarship Cover?
The scholarship covers registration to APACC 2022 and access to all virtual sessions.
What is Expected from the Scholarship Recipients?
All scholarship awardees are asked to complete all evaluations related to the conference (daily and post-conference). The surveys will be sent to each recipient by email.
Previous Editions
Media
Ratings previous edition
Content is relevant to my practice
4.8
(155)
Content was free from commercial bias
4.4
Overall event experience
4.8